Home › Appendiceal Cancer › New York
Appendiceal Cancer clinical trials in New York
4 studies for Appendiceal Cancer are looking for participants at sites in New York.
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Laura & Isaac Perlmutter Cancer Center at NYU Langone, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT07020221Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- Montefiore Medical Center-Einstein Campus, The Bronx
- James J Peters VA Medical Center, The Bronx
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07283939Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Columbia University, New York
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
- Northwell Health Cancer Institute at Huntington, Greenlawn
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT04329494From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.